Characteristics of physical activities in daily life in chronic obstructive pulmonary disease.

Quantification of physical activities in daily life in patients with chronic obstructive pulmonary disease has increasing clinical interest. However, detailed comparison with healthy subjects is not available. Furthermore, it is unknown whether time spent actively during daily life is related to lung function, muscle force, or maximal and functional exercise capacity. We assessed physical activities and movement intensity with the DynaPort activity monitor in 50 patients (age 64 +/- 7 years; FEV1 43 +/- 18% predicted) and 25 healthy elderly individuals (age 66 +/- 5 years). Patients showed lower walking time (44 +/- 26 vs. 81 +/- 26 minutes/day), standing time (191 +/- 99 vs. 295 +/- 109 minutes/day), and movement intensity during walking (1.8 +/- 0.3 vs. 2.4 +/- 0.5 m/second2; p < 0.0001 for all), as well as higher sitting time (374 +/- 139 vs. 306 +/- 108 minutes/day; p = 0.04) and lying time (87 +/- 97 vs. 29 +/- 33 minutes/day; p = 0.004). Walking time was highly correlated with the 6-minute walking test (r = 0.76, p < 0.0001) and more modestly to maximal exercise capacity, lung function, and muscle force (0.28 < r < 0.64, p < 0.05). Patients with chronic obstructive pulmonary disease are markedly inactive in daily life. Functional exercise capacity is the strongest correlate of physical activities in daily life.

[1]  P. Williams,et al.  Physical activity and public health. , 1995, JAMA.

[2]  J. Després,et al.  American College of Sports Medicine Position Stand. The recommended quantity and quality of exercise for developing and maintaining cardiorespiratory and muscular fitness, and flexibility in healthy adults. , 1998, Medicine and science in sports and exercise.

[3]  D. F. Rochester,et al.  Respiratory muscle failure. , 1983, The Medical clinics of North America.

[4]  R. Ross,et al.  ATS/ACCP statement on cardiopulmonary exercise testing. , 2003, American journal of respiratory and critical care medicine.

[5]  M. Tsukino,et al.  Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. , 2003, American journal of respiratory and critical care medicine.

[6]  Robert A Wise,et al.  Six-minute walk distance in chronic obstructive pulmonary disease: reproducibility and effect of walking course layout and length. , 2003, American journal of respiratory and critical care medicine.

[7]  S. Hurd,et al.  Global Strategy for the Diagnosis, Management and Prevention of COPD: 2003 update , 2003, European Respiratory Journal.

[8]  Z. Nahas,et al.  Functional impairment in COPD patients: the impact of anxiety and depression. , 2000, Psychosomatics.

[9]  N. N. Available.  World medical association declaration of Helsinki , 2000, Chinese Journal of Integrative Medicine.

[10]  B. Steele,et al.  Correlates of Physical Activity in Chronic Obstructive Pulmonary Disease , 2001, Nursing research.

[11]  S. Eckstein.  Ethical principles for medical research involving human subjects. , 2001, European journal of emergency medicine : official journal of the European Society for Emergency Medicine.

[12]  G. Erikssen,et al.  Physical Fitness and Changes in Mortality , 2001, Sports medicine.

[13]  J B Bussmann,et al.  Validity of ambulatory accelerometry to quantify physical activity in heart failure. , 2000, Scandinavian journal of rehabilitation medicine.

[14]  V. Mathiowetz,et al.  Grip and pinch strength: normative data for adults. , 1985, Archives of physical medicine and rehabilitation.

[15]  Y. Schutz,et al.  Walking activity measured by accelerometry during respiratory rehabilitation. , 2003, Journal of cardiopulmonary rehabilitation.

[16]  G H Guyatt,et al.  Effect of encouragement on walking test performance. , 1984, Thorax.

[17]  J. Fitting,et al.  Oxygen saturation during daily activities in chronic obstructive pulmonary disease. , 1996, The European respiratory journal.

[18]  S. Aaron,et al.  Sputum versus bronchoscopy for diagnosis of Pseudomonas aeruginosa biofilms in cystic fibrosis , 2004, European Respiratory Journal.

[19]  K. Patrick,et al.  Physical Activity and Public Health: A Recommendation From the Centers for Disease Control and Prevention and the American College of Sports Medicine , 1995 .

[20]  M. Decramer,et al.  Six minute walking distance in healthy elderly subjects. , 1999, The European respiratory journal.

[21]  P. Jones,et al.  Physiological and symptom determinants of exercise performance in patients with chronic airway obstruction. , 2000, Respiratory medicine.

[22]  Y Schutz,et al.  Assessment of free-living physical activity in humans: an overview of currently available and proposed new measures. , 2001, Obesity research.

[23]  J E Cotes,et al.  Lung volumes and forced ventilatory flows , 1993, European Respiratory Journal.

[24]  P. Jones,et al.  Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease , 1999, Thorax.

[25]  G. Sergi,et al.  Chronic obstructive pulmonary disease (COPD) in elderly subjects: impact on functional status and quality of life. , 2003, Respiratory medicine.

[26]  L. Makrides,et al.  Normal standards for an incremental progressive cycle ergometer test. , 1985, The American review of respiratory disease.

[27]  L. Mâsse,et al.  Diary days needed to estimate activity among older African-American and Hispanic women. , 2002, Medicine and science in sports and exercise.

[28]  P. Jones,et al.  Evaluation of a movement detector to measure daily activity in patients with chronic lung disease. , 1997, The European respiratory journal.

[29]  P. Freedson,et al.  Using objective physical activity measures with youth: how many days of monitoring are needed? , 2000, Medicine and science in sports and exercise.

[30]  B. Steele,et al.  Quantitating physical activity in COPD using a triaxial accelerometer. , 2000, Chest.

[31]  J. Wedzicha,et al.  Assessment and follow up of patients prescribed long term oxygen treatment. , 1993, Thorax.

[32]  David R Bassett,et al.  Sources of variance in daily physical activity levels as measured by an accelerometer. , 2002, Medicine and science in sports and exercise.

[33]  Dina Brooks,et al.  ATS statement on six-minute walk test. , 2003, American journal of respiratory and critical care medicine.

[34]  M. Decramer,et al.  Six-minute walk test: a valuable test, when properly standardized. , 2002, Physical therapy.

[35]  L. Køber,et al.  Importance of chronic obstructive pulmonary disease for prognosis and diagnosis of congestive heart failure in patients with acute myocardial infarction , 2003, European journal of heart failure.

[36]  M. Decramer,et al.  Corticosteroids contribute to muscle weakness in chronic airflow obstruction. , 1994, American journal of respiratory and critical care medicine.

[37]  L. F. Black,et al.  Maximal respiratory pressures: normal values and relationship to age and sex. , 2015 .

[38]  B. Steele,et al.  Bodies in motion: monitoring daily activity and exercise with motion sensors in people with chronic pulmonary disease. , 2003, Journal of rehabilitation research and development.

[39]  M. Morgan,et al.  Activity monitors can detect brisk walking in patients with chronic obstructive pulmonary disease. , 2001, Journal of cardiopulmonary rehabilitation.

[40]  R. Hubbard,et al.  Adverse effects of oral corticosteroids in relation to dose in patients with lung disease , 2001, Thorax.

[41]  J E Cotes,et al.  Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. , 1993, The European respiratory journal. Supplement.

[42]  P. Skerrett,et al.  Physical activity and all-cause mortality: what is the dose-response relation? , 2001, Medicine and science in sports and exercise.

[43]  S. Blair,et al.  Nutrient intake of physically fit and unfit men and women. , 2001, Medicine and science in sports and exercise.

[44]  A. Yohannes,et al.  Mortality predictors in disabling chronic obstructive pulmonary disease in old age. , 2002, Age and ageing.

[45]  Dieter Rosenbaum,et al.  Correlations between the step activity monitor and the DynaPort ADL-monitor. , 2004, Clinical biomechanics.

[46]  Wolzt,et al.  World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. , 2003, The Journal of the American College of Dentists.

[47]  RISK FACTORS OF READMISSION TO HOSPITAL FOR A COPD EXACERBATION: A PROSPECTIVE STUDY , 2003 .